PharmaCyte Biotech’s (EFYA) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting PharmaCyte Biotech is a Neutral.
PharmaCyte Biotech’s (EFYA) 20-Day exponential moving average is EUR 2.52, while PharmaCyte Biotech’s (EFYA) share price is EUR 2.52, making it a Sell.
PharmaCyte Biotech’s (EFYA) 50-Day exponential moving average is EUR 2.52, while PharmaCyte Biotech’s (EFYA) share price is EUR 2.52, making it a Buy.
PharmaCyte Biotech’s (EFYA) 10-Day exponential moving average is EUR 2.52, while PharmaCyte Biotech’s (EFYA) share price is EUR 2.52, making it a Neutral.
PharmaCyte Biotech’s (EFYA) 100-Day exponential moving average is EUR 2.52, while PharmaCyte Biotech’s (EFYA) share price is EUR 2.52, making it a Sell.
PharmaCyte Biotech’s (EFYA) stock price is EUR 2.52 and PharmaCyte Biotech’s (EFYA) 50-day simple moving average is EUR 2.52, creating a Buy signal.
PharmaCyte Biotech’s (EFYA) stock price is EUR 2.52 and PharmaCyte Biotech’s (EFYA) 100-day simple moving average is EUR 2.52, creating a Sell signal.
PharmaCyte Biotech’s (EFYA) stock price is EUR 2.52 and PharmaCyte Biotech’s (EFYA) 200-day simple moving average is EUR 2.52, creating a Buy signal.